All sites	C00-96,D32-33,D42-43,D45-47,D76	3437	91.8	2.6	2.6	0.8	2.2
Mouth, pharynx	C00-14	73	95.9	1.6	0.8	1.1	0.5
Lip	C00	10	100.0	-	-	-	-
Tongue	C02	14	98.5	1.5	-	-	-
Mouth, other	C03-06	16	97.5	-	-	2.5	-
Salivary glands	C07-08	7	86.5	8.1	2.7	-	2.7
Pharynx	C01,C09-14	25	94.5	1.6	1.6	1.6	0.8
Digestive organs	C15-26	684	89.5	1.6	4.6	1.4	3.0
Oesophagus	C15	42	91.5	0.9	1.4	0.9	5.2
Stomach	C16	77	96.4	1.0	0.8	0.8	1.0
Small intestine	C17	14	95.7	-	-	2.9	1.4
Colon	C18	195	97.6	-	0.6	0.5	1.2
Rectum, rectosigmoid	C19-20	148	97.2	-	0.8	0.8	1.2
Anus	C21	5	100.0	-	-	-	-
Liver	C22	64	82.3	1.9	9.6	2.2	4.0
Gallbladder, bile ducts	C23-24	24	73.3	5.0	11.7	2.5	7.5
Pancreas	C25	103	66.4	6.4	16.9	3.5	6.8
Other digestive organs	C26	11	66.1	3.6	12.5	5.4	12.5
Respiratory organs	C30-39	357	74.2	10.9	9.0	1.7	4.3
Nose, sinuses	C30-31	4	100.0	-	-	-	-
Larynx, epiglottis	C32	23	98.3	-	-	0.9	0.9
Lung, trachea	C33-34	327	72.4	11.8	9.7	1.8	4.3
Mediastinum, pleura	C38	2	70.0	10.0	20.0	-	-
Bone	C40-41	5	100.0	-	-	-	-
Melanoma of the skin	C43	146	99.9	0.1	-	-	-
Skin, non-melanoma	C44	184	99.7	0.2	-	-	0.1
Mesothelioma	C45	12	98.3	-	-	-	1.7
Autonomic nervous system	C47	1	100.0	-	-	-	-
Soft tissues	C48-49	20	95.0	-	3.0	-	2.0
Breast	C50	7	97.0	-	-	-	3.0
Male genital organs	C60-63	1184	99.7	-	0.0	0.1	0.2
Prostate	C61	1150	99.7	-	0.0	0.1	0.2
Testis	C62	26	100.0	-	-	-	-
Other male genital	C60,C63	7	100.0	-	-	-	-
Urinary organs	C64-68	298	94.2	1.2	2.2	0.9	1.6
Kidney	C64	106	91.7	0.4	4.2	0.9	2.8
Bladder and urinary tract2	C65-68	192	95.5	1.7	1.0	0.8	0.9
Eye	C69	3	62.5	6.3	18.8	6.3	6.3
Brain, central nervous system	C70-72,D32-33,D42-43	82	87.5	-	6.4	0.5	5.6
Thyroid gland	C73	25	96.0	4.0	-	-	-
Other endocrine glands	C74-75	4	84.2	-	5.3	-	10.5
Illdefined or unknown	C76,C80	64	67.4	6.6	14.4	3.8	7.8
Lymphoid and haematopoietic tissue	C81-96,D45-47,D76	292	80.5	9.5	1.3	1.0	7.8
Hodgkin lymphoma	C81	22	100.0	-	-	-	-
Non-Hodgkin lymphoma	C82-86,C96,D76	127	99.1	0.5	-	-	0.5
Malignant immunoproliferative diseases	C88	5	65.2	21.7	-	8.7	4.3
Myeloma and other plasma cell tumors	C90	37	57.1	13.0	9.8	2.7	17.4
Leukaemia	C91-95	71	68.7	21.7	0.3	1.4	7.9
Myelodysplastic syndromes	D46	12	31.1	18.0	-	1.6	49.2
Myeloproliferaitive neoplasms	D45,D47	18	57.6	20.7	-	1.1	20.7
Not included above
Basal cell carcinoma of the skin		787	100.0	-	-	-	-

¹ The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
² PUNLMP and ca in situ of the uroepithelium are included.